GS

Gurucharan Singh Inderjit Singh Gandhi

Director Director DIN 10178598
DIN 10178598 First appointment May 2023 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Past companies 2 historical roles
Total affiliations 2 Since May 2023
Shareholding value •••• Premium profile

About Gurucharan Singh Inderjit Singh Gandhi

Data last updated:

Gurucharan Singh Inderjit Singh Gandhi was a Director at Phoenix Medtech India Private Limited (2024–2025) and Additional Director at Deva Lifesciences Private Limited (2023–2025). The companies operate in Pharma.

DIN 10178598
Primary Designation Director
Industry Pharma
First Appointment 29 May 2023

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director15 Mar 20242024Active
Deva Lifesciences Private Limited U46497PN2023PTC220443
Additional Director29 May 20232023₹3.14 Cr (FY 2024)Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Phoenix Medtech India Private Limited
Deva Lifesciences Private Limited
Premium access

Shareholding and investment profile for Gurucharan Singh Inderjit Singh Gandhi

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Gurucharan Singh Inderjit Singh Gandhi

Gurucharan Singh Inderjit Singh Gandhi was first appointed on 29 May 2023 as Additional Director at Deva Lifesciences Private Limited. The most recent appointment on record is 15 Mar 2024 at Phoenix Medtech India Private Limited.

Gurucharan Singh Inderjit Singh Gandhi held 2 earlier board appointments: Phoenix Medtech India Private Limited (Director, 15 Mar 2024 to 12 Apr 2025); Deva Lifesciences Private Limited (Additional Director, 29 May 2023 to 22 Sep 2025).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available